Geordi Frere
@geordifrere.bsky.social
480 followers 410 following 39 posts
I used to spin things 🧲, now I weigh them ⚖️ Postdoc in the Gygi Lab at Harvard Medical School | Chemoproteomics & Chemical Biology | PhD in Chemistry, Gunning & Prosser labs at the University of Toronto | Rugby 🏉 & D&D 🎲
Posts Media Videos Starter Packs
geordifrere.bsky.social
Why does the donut display at the Buffalo airport Timmies look better than any I've seen in Canada?
geordifrere.bsky.social
I've got to try it sometime! So many interesting facets to this mechanism: N-to-O acyl shift to the diazoacetate (not sure if intramolecular as Huisgen proposed or if intermolecular between identical N-nitrosoamides), benzylic methyl activation, and a cool cyclization step!
doi.org/10.1002/jlac...
geordifrere.bsky.social
Now for the mechanistic discussion: do you think this reaction proceeds through intramolecular benzylic activation followed by nitrene formation and cyclization, or through diazotization followed by deprotonation by acetate and cyclization?
geordifrere.bsky.social
An #organicchemistry mechanistic puzzle for your Saturday morning coffee: the Jacobsen-Huisgen indazole synthesis! This reaction was used to synthesize Lilly's oral GLP-1 agonist orforglipron (patents.google.com/patent/US202...). Take a crack at the mechanism, then see the question below!
The Jacobsen-Huisgen indazole synthesis
geordifrere.bsky.social
New preprint by Chris Parker on target-agnostic PROTACs comprising diverse target-binding moieties linked to a CRBN ligand to explore the degradable proteome. Proteomic profiling identified >50 proteins that were degraded by this library, revealing potential starting points for PROTAC development.
Proteome-Wide Discovery of Degradable Proteins Using Bifunctional Molecules
Targeted protein degradation (TPD) is an emergent therapeutic strategy with the potential to circumvent challenges associated with targets unamenable to conventional pharmacological inhibition. Among ...
www.biorxiv.org
geordifrere.bsky.social
A crystal structure of tubulin-RB3 bound to a colchicine site inhibitor showed another binding site at the RB3 interface. An optimized compound with no colchicine site affinity retained antimicrotubule activity through stathmin complex stabilization. #inducedproximity #molecularglues
Optimized tumabulin is selective for the new site
geordifrere.bsky.social
A new paper in PNAS identifies tumabulin-2 as a #molecularglue targeting the tripartite interface of α-tubulin, β-tubulin, & RB3 to elicit a novel mechanism of microtubule disruption via stabilization of a polymer-incompatible complex & sequestration of tubulin dimers!
www.pnas.org/doi/10.1073/...
Crystal structure of tumabulin with tubulin-RB3 reveals a novel binding site and molecular glue mechanism
geordifrere.bsky.social
Importantly, the authors don't observe alkylamine biotransformation into an electrophilic aldehyde as has been reported for other FBXO22-recruiting #degraders.
geordifrere.bsky.social
Although this reaction proceeds in a SMARCA-independent manner in vitro (potentially due to artificially high compound & protein concentrations), the true event may proceed through template-assisted #covalent modification, akin to the DCAF16-recruiting BRD4 degraders of Nathanael Gray et al.
geordifrere.bsky.social
Using an unconventional 2-alkynylpyridine warhead, G-6599 covalently engages cysteines (predominantly C228 and C326) in FBXO22 to facilitate SMARCA2/4 degradation.
geordifrere.bsky.social
Researchers at Genentech published an interesting preprint describing the discovery of a #monovalent electrophilic #degrader of SMARCA2/4 that acts as a #molecularglue mediating an interaction with "frequent hitter" E3 ligase FBXO22.
www.biorxiv.org/content/10.1...
geordifrere.bsky.social
The increased thermal stability of BEHT triflate over azodicarboxylates, combined with its long-term shelf stability, commercial availability, and expanded nucleophile scope should translate into sweeping uptake by industry!
geordifrere.bsky.social
A major breakthrough for the Mitsunobu reaction! New work from the Charette lab at UMontreal reports a universal Mitsunobu reagent with no limitation on nucleophile pKa, expanding substrate scope to include primary & secondary amines that were previously incompatible with this reaction!
Universal Reagent for Mild and Stereospecific Nucleophilic Substitution of Alcohols with Amines
A user-friendly, shelf-stable protonated betaine reagent (BEHT triflate), derived from Mitsunobu reagents, has been developed to enable the direct displacement of alcohols using primary and secondary...
onlinelibrary.wiley.com
geordifrere.bsky.social
"Courts halt appeal Trump unfreeze to cash immediate all order administration required federal"
geordifrere.bsky.social
This is the most convoluted headline I've ever read
apnews.com/article/trum...
geordifrere.bsky.social
Funding stagnation has rendered Canada uncompetitive in global biomedical research, and further fuels the accelerating exodus of scientists from Canada. Quelling this tide requires systemic increases to CIHR grants and equitable financial support for all academic trainees.
Two decades of stagnant funding have rendered Canada uncompetitive in biomedical research. Here’s why it matters, and how to fix it. - Academic Matters
academicmatters.ca
geordifrere.bsky.social
For many scientific trainees, the prospect of pursuing a Canadian postdoc's meager salary is financially daunting at best and laughable at worst, causing leading Canadian institutions to miss out on top talent.
geordifrere.bsky.social
In the same period, the success rate for CIHR grants has decreased from 33% to just 19%, and the cost of lab supplies continue to skyrocket.

Canada's CIHR budget is 50 times lower than that of the NIH, while our population is only nine times smaller than the US.
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
geordifrere.bsky.social
Even after the much-needed increase in CIHR scholarship stipends, fewer than 10% of grad students and postdocs receive these awards. All other trainees rely upon funding supplemented by their supervisors, drawing from CIHR funding that hasn't increased in 20 years.
www.nature.com/articles/d41...
Canada’s postgraduate funding gap is still yawning even after budget increases
Letter to the Editor
www.nature.com
geordifrere.bsky.social
Michael: "Janet, could you draw the mechanism for the Dess-Martin oxidation?"

Janet: "Here you go!"

Michael: *long pause, resigned nod* "...Thank you, Janet."
Abysmal DALL-E attempt at the Dess-Martin oxidation mechanism.
geordifrere.bsky.social
On top of the usual suspects, they evaluate inhibitors of the deneddylase CSN, the Ub receptor Rpn13, & the unfoldase VCP/p97 as controls for degradation rescue studies. They also show that the E1 inhibitor PYR-41 did not rescue degradation at any dose tested, recommending TAK-243 for this purpose.